We are live on ! Find out more
NA

Neuburgh Advisers Portfolio holdings

AUM $3.22B
1-Year Est. Return 3.74%
This Fund
S&P 500
This Quarter Est. Return
+3.29%
1 Year Est. Return
+3.74%
3 Year Est. Return
+55.12%
5 Year Est. Return
10 Year Est. Return
AUM
$3.11B
AUM Growth
+$165M
Cap. Flow
+$95.7M
Cap. Flow %
3.08%
Top 10 Hldgs %
25.98%
Holding
938
New
28
Increased
354
Reduced
207
Closed
26

Top Sells

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$16.8M
2
SNA icon
Snap-on
SNA
+$12.1M
3
AAPL icon
Apple
AAPL
+$11.3M
4
DD icon
DuPont de Nemours
DD
+$10.4M
5
BNY
Bank of New York Mellon
BNY
+$9.14M

Sector Composition

Rank Sector Weight
1 Healthcare 19.09%
2 Financials 15.65%
3 Technology 15.03%
4 Consumer Discretionary 11.67%
5 Industrials 9.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCJ icon
876
Cameco
CCJ
$37.6B
$32K ﹤0.01%
3,080
+352
+13% +$3.79K
UPLD icon
877
Upland Software
UPLD
$12.8M
$31K ﹤0.01%
68
VRTV
878
DELISTED
VERITIV CORPORATION
VRTV
$31K ﹤0.01%
1,584
+256
+19% +$5.9K
ONC
879
BeOne Medicines Ltd
ONC
$32.8B
$28K ﹤0.01%
224
+32
+17% +$4.06K
APPF icon
880
AppFolio
APPF
$6.38B
$27K ﹤0.01%
264
VET icon
881
Vermilion Energy
VET
$1.82B
$27K ﹤0.01%
1,296
+80
+7% +$1.87K
CSOD
882
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$26K ﹤0.01%
442
CAE icon
883
CAE Inc. Common Shares
CAE
$8.3B
$25K ﹤0.01%
976
+32
+3% +$782
FIVN icon
884
FIVE9
FIVN
$2.11B
$24K ﹤0.01%
462
ALEC icon
885
Alector
ALEC
$168M
$23K ﹤0.01%
1,190
OPTU
886
Optimum Communications Inc
OPTU
$298M
$23K ﹤0.01%
928
-16
-2% -$380
MYOK
887
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$21K ﹤0.01%
416
REPL icon
888
Replimune Group
REPL
$941M
$20K ﹤0.01%
1,394
GDDY icon
889
GoDaddy
GDDY
$11B
$19K ﹤0.01%
264
KALV
890
DELISTED
KalVista Pharmaceuticals
KALV
$19K ﹤0.01%
836
SNDX icon
891
Syndax Pharmaceuticals
SNDX
$1.69B
$19K ﹤0.01%
2,048
SILK
892
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$17K ﹤0.01%
+352
New +$15K
XLI icon
893
State Street Industrial Select Sector SPDR ETF
XLI
$32.8B
$16K ﹤0.01%
204
-578
-74% -$44K
VRNT
894
DELISTED
Verint Systems
VRNT
$14K ﹤0.01%
503
HRTX icon
895
Heron Therapeutics
HRTX
$93.9M
$13K ﹤0.01%
+688
New +$13.7K
MAT icon
896
Mattel
MAT
$4.38B
$13K ﹤0.01%
1,120
-20,496
-95% -$241K
ALTR
897
DELISTED
Altair Engineering Inc
ALTR
$13K ﹤0.01%
320
CHMA
898
DELISTED
Chiasma, Inc. Common Stock
CHMA
$13K ﹤0.01%
1,734
+170
+11% +$1.11K
SSTI icon
899
SoundThinking
SSTI
$100M
$12K ﹤0.01%
272
-1,360
-83% -$63.6K
CBAY
900
DELISTED
Cymabay Therapeutics
CBAY
$12K ﹤0.01%
1,738

Similar funds

Neuburgh Advisers's Q2 2019 Portfolio in Review

As of Q2 2019, Neuburgh Advisers held 938 positions worth $3.11B, up 5.6% from $2.94B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Neuburgh Advisers deployed $95.7M of net new capital in Q2 2019, opening 28 new positions and adding to 354 existing holdings. Its largest new stake was Dow Inc: 46,716 shares worth $2.3M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was RTX Corp, an estimated $16.8M trimmed.

  • Neuburgh Advisers's largest Q2 2019 buy was Dow Inc: 46,716 shares worth $2.3M.
  • Neuburgh Advisers added most to iShares Russell 1000 Growth ETF in Q2 2019, an estimated $48.6M increase.
  • Neuburgh Advisers's biggest Q2 2019 reduction was RTX Corp, cutting an estimated $16.8M.
  • Neuburgh Advisers fully exited L3Harris in Q2 2019, selling an estimated $7.08M.
  • Neuburgh Advisers's ten largest holdings make up 26% of its $3.11B portfolio in Q2 2019.
  • Neuburgh Advisers opened 28 new positions and closed 26 in Q2 2019.
  • Neuburgh Advisers's portfolio value rose 5.6% quarter-over-quarter to $3.11B.

Based on Neuburgh Advisers's 13F filing for Q2 2019, filed 13 Aug 2019.